Popular Articles
Teeth Whitening

FDA Approves Besivance To Treat Bacterial Conjunctivitis
The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
generic viagra online
Welsh Assembly Government Written Statement On Swine Influenza, Wlales
This statement updates Members on the Influenza A (H1N1v) swine flu outbreak and the latest developments in Wales and across the UK.
News of the day
Compliance And Cost: Bitter Pills To Swallow In The Age Of Oral Chemotherapy
Though the growing shift toward oral chemotherapy agents offers cancer patients greater freedom and independence during their treatment, physicians say use of the new medications also poses more chances for patients to skip doses, miss prescription refills, and take their drugs in a dangerous way. An increasing number of cancer patients who receive chemotherapy now do so at home, with the click of a pill bottle each day rather than the drip of an IV medicine that must be delivered in a doctor"s office or hospital.
Medical Devices

Patient Notes - Clarity For Insurers And Doctors

Doctors will have greater clarity around releasing a patient"s full medical notes to insurance companies after the Privacy Commissioner concluded that the law allows insurers to collect only the information that they need to make insurance decisions. The Privacy Commissioner received a request from the New Zealand Medical Association (NZMA) to look into insurers" requests for full patient notes. The Commissioner concluded that insurance companies can only ask for patient notes that are of direct relevance to their decision to insure a person or to pay on a claim. "Medical practitioners should expect that the first request from an insurer will be of a more limited nature, such as questions about specific conditions," says NZMA GP Chair Dr Mark Peterson. "In some cases insurers may follow up by requesting more detailed information on a patient"s full notes for a specified period but both the insurer and the doctor will need to ensure that they have the patient"s permission to release additional information." Insurers have said they are willing to make their forms clearer - taking on board the Privacy Commissioner"s conclusions - so that if they intend to collect medical information there is no confusion for patients and doctors. The NZMA has produced a re for members, which reflects the results of the Commissioner"s inquiry. "If a doctor is uncertain whether a patient has authorised disclosure they need to discuss the matter with their patient," says Dr Peterson. "Patients may also want to see their medical notes before they make a decision on authorising disclosure." The Commissioner has said that occasionally an insurer will be entitled to collect full medical notes, if the more specific information does not provide the detail the insurer needs to make a decision. However, these situations should be rare. New Zealand Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):